Public Health

When cancer specialists embrace – and when they avoid – this revolutionary drug class.

GLP-1 therapies have redefined what obesity pharmacotherapy can achieve, but efficacy is no longer the only battleground.

A monthly dispatch of Ipsos’ best insights on the U.S., tailored for the world.

Ipsos' Essentials infographics offer insights on how consumers think, feel, and engage in activities such as shopping, travel, entertainment, socialization, technology and AI, and work in our dynamic, ever-changing world.

Turn longevity from trend to strategy: where should pharma play - and how to win?

Despite media discussions around the drugs, only around a third across 30 countries have heard about the drugs, with a lot of the discourse taking place via social media according to the Ipsos Health Service Report.

Read our new viewpoint and delve into the paradox of early cancer detection: how expanding screening methods – particularly multi-cancer early detection tests – while life-saving, pose considerations such as psychological impacts, false positives, and ethical dilemmas.

Ipsos’ latest AI-powered innovation offers unparalleled insights into the fast-moving consumer obesity treatment market – while reinforcing Ipsos’ position at the forefront of AI applications in market research.

Amidst global temperature rise concerns, Ipsos uncovers declining individual action despite heightened awareness. Spanning 32 countries, our report reveals regional differences in climate policy expectations and economic apprehensions, providing a roadmap for strategic climate engagement.